Early cardiac rehabilitation after mitral or aortic valve replacement

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

In Qena, Egypt, 60 patients aged 40–60 who underwent elective mitral or aortic valve replacement were randomized to a phase one cardiac rehabilitation program or routine postoperative physical therapy. The rehabilitation group received supervised physical exercises and respiratory training while the control group received standard clinic care. Outcomes included oxygen saturation, spirometry measures, and the six-minute walk test, all measured before and after six consecutive weeks of the assigned program. The trial focused on short-term changes in cardiovascular function, pulmonary capacity, and functional ability.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* The inclusion criteria was elective mitral or aortic valve replacement
* and to be hemodynamically stable to qualify for a structured rehabilitation program.
* Being able to understand and complete measurements.
* And provide informed written consent.

Exclusion Criteria:

* Patient with ischemic heart disease before surgery.
* Those with severe musculoskeletal system disorders.
* Patients who had persistent or paroxysmal atrial fibrillation.
* Individuals with severe heart failure.
* uncontrolled arrhythmias.
* Comorbidity complicating physical activity or other contraindications to phase one cardiac rehabilitation and Patients who underwent an emergency surgical intervention.

Where it's running

• South valley university
  Qina, Egypt Recruiting

Study contacts

• Study coordinator: Shymaa Yussuf Abo-Zaid, Lecturer
• Email: shaymaayoussef397@gmail.com
• Phone: 01010941685

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Aspirin vs Warfarin after Bioprosthetic Heart Valve Replacement

  This trial tests whether aspirin or warfarin is safer during the first 6 months after a bioprosthetic heart valve is placed.

  Recruiting Phase 4 Asan Medical Center · Osaka and 2 other locations · NCT07431762

• SYMmetric Valve expansion to reduce hypoattenuated leaflet thickening after balloon-expandable TAVI

  This trial tests whether the Double-TAP post-dilatation strategy can reduce HALT and improve valve function in patients 70 or older undergoing balloon-expandable TAVI.

  Recruiting Erasmus Medical Center · Düsseldorf and 4 other locations · NCT07872020

• Low-dose Colchicine after TAVR to help prevent valve clots

  This study tests whether taking a low dose of colchicine for 12 months after transcatheter aortic valve replacement can reduce valve thrombosis compared with standard care alone.

  Recruiting China National Center for Cardiovascular Diseases · Beijing · NCT07411768

• Transcatheter Mitral and Tricuspid Interventions and Cardiac MRI Registry

  This study will collect imaging and clinical data from adults undergoing transcatheter mitral or tricuspid procedures to see how their heart structure and function change over time using MRI and advanced ultrasound.

  Recruiting Centro Cardiologico Monzino · Milan, Milan · NCT07370467

• Evaluation of the Point-Guard device during heart valve replacement

  This study is testing a new device called Point-Guard to see if it can help prevent brain problems during heart valve replacement surgery.

  Recruiting Transverse Medical, Inc. · Clayton, Victoria · NCT06962371

• Single versus Dual Perclose Device Closure for Large-Bore Femoral Access in TAVR

  This will test whether using one Perclose device instead of two closes large-bore femoral access faster and with similar or fewer complications in people having transfemoral TAVR.

  Recruiting Wake Forest University Health Sciences · Milwaukee, Wisconsin · NCT06871774

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.